title: [Can they make a complaint against me if I have a complication on administering bebacizumab (Avastin)?].
authors.affiliation: Servicio de Oftalmología, Hospital Universitario Montepríncipe, Madrid, España. Electronic address: jamenendezdelucas@yahoo.es.
authors.forename: J A
authors.initials: JA
authors.lastname: Menéndez de Lucas
authors.affiliation: Servicio de Oftalmología, Hospital Universitario Montepríncipe, Madrid, España.
authors.forename: V
authors.initials: V
authors.lastname: Molina Seoane
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000068258:Bevacizumab / Q000008:administration & dosage / Q000009:adverse effects*; D057176:Compassionate Use Trials / Q000331:legislation & jurisprudence; D006801:Humans; D008318:Malpractice; D009885:Ophthalmology / Q000331:legislation & jurisprudence*; D013030:Spain
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab